The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients

Clinical and Experimental Rheumatology

Volumn 22, Issue 4 SUPPL. 24, 2004, Pages

  Calguneri, Meral ^a   Apras, Sule ^a   Ozbalkan, Zeynep ^a,b   Ozturk, M Akif ^a   Ertenli, Ihsan ^a   Kiraz, Sedat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Colchicine; Familial Mediterranean fever; Interferon alpha; Resistance

Indexed keywords

ALPHA INTERFERON; COLCHICINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE; C REACTIVE PROTEIN; FIBRINOGEN; LIVER ENZYME; PARACETAMOL; IMMUNOLOGICAL ADJUVANT;

ABDOMINAL PAIN; ADULT; ANKLE; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; FEVER; HUMAN; KNEE ARTHRITIS; MALE; PERITONITIS; PRIORITY JOURNAL; SEROSA; SIDE EFFECT; VASCULITIS; DISEASE DURATION; DRUG RESPONSE; DRUG TREATMENT FAILURE; ERYTHROCYTE SEDIMENTATION RATE; FIBRINOGEN BLOOD LEVEL; HYPERTRANSAMINASEMIA; PILOT STUDY; TREATMENT DURATION; TREATMENT OUTCOME; ANAPHYLACTOID PURPURA; ANKYLOSING SPONDYLITIS; CHRONIC ARTHRITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE SEVERITY; LIVER DYSFUNCTION; OPPORTUNISTIC INFECTION; POLYARTERITIS NODOSA; SACROILIITIS; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; INFLAMMATION; PATHOLOGY;

ADJUVANTS, IMMUNOLOGIC; ADULT; COLCHICINE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; MALE; SEROSITIS;

EID: 5444235782     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. DRENTH J, Van der MEER J: Hereditary periodic fever. N Engl J Med 2001; 345: 1748-57.
2. BEN-CHETRIT E, LEVY M: Familial Mediterranean fever. Lancet 1998; 351: 659-63.
3. SHIOZAWA S, MORIMOTO I, TANAKA Y, SHIOZAWA K: A preliminary study on the interferon-alpha treatment for xerostomia of Sjögren's syndrome. Br J Rheumatol 1993, 32: 52-4.
4. KNOBLER RL, PANITCH HS, BRAHENY SL et al.: Systemic alpha-interferon therapy of multiple sclerosis. Neurology 1984; 34: 1273-9.
5. GEORGIOU S, MONASTIRLI A, PASMATZI E, GARTAGANIS S, GOERZ G, TSAMBAOS D: Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease. J Intern Med 1998; 243: 367-72.
6. MATZNER Y, AYESH SK, HOCHNER-CELNIKER D et al.: Proposed mechanism of the inflammatory attacks in familial Mediterranean fever. Arch Intern Med 1990; 150: 1289-91.
7. SCHATTNER A, HAHAN T: A proposed mechanism of the inflammatory attacks in familial Mediterranean fever. Arch Intern Med 1992; 152: 421-6.
8. CENTOLA M, WOOD G, FRUCHT DM et al.: The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-31.
9. TUNCA M, TANKURT E, AKPINAR AH, AKAR S, HIZLI N, GONEN O: The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study. Br J Rheumatol 1997; 36: 1005-8.
10. LIVNEH A, LANGEVITZ P, ZEMER D et al.: Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1998; 41: 1516-7.
11. DINARELLO CA, WOLF SM, GOLDFINGER SE, DALE DC: Colchicine therapy for familial Mediterranean fever. A double-blind trial. N Engl J Med 1974; 291: 934-7.
12. CLARKE S, GORDON S: Myeloid-specific gene expression. J Leukoc Biol 1998; 63: 153-68.
13. GASPERINI S, MARCHI M, CALZETTI F et al.: Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 1999; 162: 4928-37.
14. OZEN S, UCKAN D, BASKIN E et al.: Increased neutrophil appopitosis during attacks of familial Mediterranean fever. Clin Exp Rheumatol 2001; 19: 68-71.
15. ABEDAT S, URIELI-SHOVAL S, SHAPIRA E, CALKO S, BEN-CHETRIT E, MATZNER Y: Effects of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures. Isr Med Assoc 2002; 4: 7-12.
16. TUNCA M, BEN-CHETRIT E: Familial Mediterranean fever in 2003. Pathogenesis and management. Clin Exp Rheumatol 2003; 21